MedicarePartD.guide

A non-government resource built from CMS public data

METRONIDAZOLE 10 mg/g Gel

Coverage in Connecticut, Massachusetts, Rhode Island and Vermont (CMS PDP Region 02).

6 of 11 stand-alone Part D plans in Connecticut, Massachusetts, Rhode Island and Vermont cover this drug on tier 4.

No plan applies a prior authorization, step therapy or quantity limit.

122 Medicare Advantage plans in CT, MA, RI, VT do cover it

Medicare Advantage plans carry their own formularies, separate from stand-alone Part D. A patient on an MA-PD plan may have coverage even where no PDP lists the drug. CT: 29 plans · MA: 73 plans · RI: 18 plans · VT: 2 plans.

Every plan that covers it

PlanTier30-day preferred90-day mailUnit costEst. 30-day fillRestrictions
Humana Basic Rx Plan (PDP)$8.40/mo premium · $615.00 deductible4Non-Preferred Drug32%—$1.3690—None
SilverScript Choice (PDP)$32.70/mo premium · $615.00 deductible4Non-Preferred Drug35%35%$1.2913—None
Humana Value Rx Plan (PDP)$73.60/mo premium · $601.00 deductible4Non-Preferred Drug31%—$1.3768—None
Humana Premier Rx Plan (PDP)$138.60/mo premium · $0.00 deductible4Non-Preferred Drug50%50%$1.3647—None
HealthSpring Assurance Rx (PDP)$139.30/mo premium · $615.00 deductible4Non-Preferred Drug31%31%$1.1791—None
AARP Medicare Rx Preferred from UHC (PDP)$155.10/mo premium · $130.00 deductible4Non-Preferred Drug30%—$1.1407—None

Cost-sharing is the initial coverage phase at a preferred pharmacy; a percentage is coinsurance of the plan’s negotiated price, and the deductible may apply first. CMS publishes a negotiated price per unit, so the 30-day fill is shown only where the plan’s own quantity limit supplies the quantity.

See coverage in all 39 regions →